Oncotelic Therapeutics Collaborates on Biomarker Study Published in International Journal of Molecular Sciences
Oncotelic Therapeutics' collaborative study reveals the context-dependent prognostic significance of biomarkers DNMT3A and GMPS in liver and pancreatic cancers, highlighting the importance of tumor microenvironment analysis for advancing personalized oncology treatments.
Read the full story



























